Rubric Capital Management (New York)’s Roivant Sciences ROIV Stock Holding History

Rubric Capital Management (New York)’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212M	Buy	6,000,000 +1,000,000	+20%	+$29.6M	1.95%	15
2026 Q1	$139M	Sell	5,000,000 -4,000,000	-44%	-$103M	1.47%	17
2025 Q4	$195M	Sell	9,000,000 -11,000,000	-55%	-$217M	2.34%	10
2025 Q3	$303M	Sell	20,000,000 -370,336	-2%	-$4.58M	3.41%	7
2025 Q2	$230M	Buy	20,370,336 +2,603,260	+15%	+$28.2M	3.47%	6
2025 Q1	$179M	Sell	17,767,076 -2,232,924	-11%	-$24.1M	3.21%	7
2024 Q4	$237M	Sell	20,000,000 -2,400,000	-11%	-$28.4M	3.04%	8
2024 Q3	$258M	Sell	22,400,000 -600,000	-3%	-$6.83M	4.21%	3
2024 Q2	$243M	Buy	23,000,000 +3,000,000	+15%	+$32.9M	6.37%	2
2024 Q1	$211M	Buy	20,000,000 +1,000,000	+5%	+$10.8M	6.23%	3
2023 Q4	$213M	Buy	19,000,000 +8,500,000	+81%	+$82.8M	4.43%	2
2023 Q3	$123M	Buy	10,500,000 +6,963,562	+197%	+$78.7M	4.6%	5
2023 Q2	$35.6M	Sell	3,536,438 -2,063,562	-37%	-$18.5M	1.52%	28
2023 Q1	$41.3M	Buy	5,600,000 +2,600,000	+87%	+$21.4M	1.07%	21
2022 Q4	$24M	Buy	+3,000,000	New	+$16.7M	1.05%	32

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Rubric Capital Management (New York)'s ROIV Position: Q2 2026 in Review

Rubric Capital Management (New York) increased its Roivant Sciences (ROIV) stake by 20% in Q2 2026, buying an estimated $29.6M and bringing the position to 6,000,000 shares worth $212M. The position accounts for 1.95% of the portfolio, ranked #15.

Rubric Capital Management (New York) first reported a position in ROIV in Q4 2022 and has held it in 15 quarters since. The position peaked at $303M in Q3 2025. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Rubric Capital Management (New York) held 6,000,000 shares of Roivant Sciences worth $212M as of Q2 2026.
Rubric Capital Management (New York) bought 1,000,000 Roivant Sciences shares in Q2 2026, an estimated $29.6M.
Roivant Sciences made up 1.95% of Rubric Capital Management (New York)'s portfolio in Q2 2026, its #15 holding.
Rubric Capital Management (New York) first reported a position in Roivant Sciences in Q4 2022 and has held it in 15 quarters since.
Rubric Capital Management (New York)'s Roivant Sciences position peaked at $303M in Q3 2025.
499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.